Daily Stock Analysis, EDC, EDAP TMS SA -ADR, priceseries

EDAP TMS SA -ADR. Daily Stock Analysis
Stock Information
Open
56.17
Close
54.10
High
56.50
Low
54.00
Previous Close
56.83
Daily Price Gain
-2.73
YTD High
96.66
YTD High Date
Jan 13, 2020
YTD Low
20.75
YTD Low Date
Mar 18, 2020
YTD Price Change
-39.38
YTD Gain
-42.12%
52 Week High
96.66
52 Week High Date
Jan 13, 2020
52 Week Low
20.75
52 Week Low Date
Mar 18, 2020
52 Week Price Change
-11.85
52 Week Gain
-17.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
52.97
Feb 24. 2017
67.66
36 Trading Days
27.75%
Link
LONG
Jul 11. 2017
85.09
Aug 9. 2017
97.05
21 Trading Days
14.05%
Link
LONG
Aug 21. 2017
96.68
Sep 5. 2017
102.04
10 Trading Days
5.54%
Link
LONG
Dec 27. 2017
118.12
Jan 30. 2018
151.07
22 Trading Days
27.89%
Link
LONG
Jan 4. 2019
63.84
Feb 7. 2019
76.45
23 Trading Days
19.76%
Link
LONG
Jun 18. 2019
72.23
Jul 5. 2019
76.92
12 Trading Days
6.50%
Link
LONG
Aug 29. 2019
60.08
Sep 19. 2019
67.97
14 Trading Days
13.13%
Link
LONG
Oct 10. 2019
64.77
Nov 11. 2019
75.31
22 Trading Days
16.27%
Link
LONG
Dec 10. 2019
73.62
Jan 6. 2020
86.92
17 Trading Days
18.07%
Link
LONG
May 29. 2020
37.40
Jun 11. 2020
42.92
9 Trading Days
14.77%
Link
LONG
Jul 1. 2020
45.98
Jul 16. 2020
53.69
10 Trading Days
16.77%
Link
Company Information
Stock Symbol
EDC
Exchange
NASDAQ
Company URL
http://www.edap-tms.com
Company Phone
69120 VAULX EN VELIN I0
CEO
Marc Oczachowski
Headquarters
-
Business Address
PARC D'ACTIVITES LA POUDRETTE LAMARTINE, 4 RUE DU DAUPHINE
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001041934
About

Description

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.